Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,825 | 5 | 60.0% |
| Consulting Fee | $5,920 | 2 | 21.1% |
| Food and Beverage | $2,736 | 85 | 9.8% |
| Unspecified | $2,540 | 4 | 9.1% |
| Education | $3.86 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $23,072 | 25 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $3,227 | 10 | $0 (2024) |
| GENZYME CORPORATION | $525.44 | 25 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $263.91 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $253.09 | 3 | $0 (2024) |
| Lilly USA, LLC | $252.69 | 4 | $0 (2023) |
| Incyte Corporation | $156.16 | 4 | $0 (2024) |
| Verrica Pharmaceuticals Inc. | $82.23 | 2 | $0 (2024) |
| Krystal Biotech Inc | $57.73 | 3 | $0 (2024) |
| ABBVIE INC. | $57.26 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,546 | 25 | PFIZER INC. ($9,952) |
| 2023 | $17,456 | 71 | PFIZER INC. ($13,120) |
| 2022 | $22.76 | 1 | ABBVIE INC. ($22.76) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Novartis Pharmaceuticals Corporation | VIJOICE (Drug) | Food and Beverage | In-kind items and services | $108.60 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Verrica Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $61.09 | General |
| 09/25/2024 | PFIZER INC. | LITFULO (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: LITFULO CLINICAL PUBLICATION PROGRAM • Category: IMMUNOLOGY | ||||||
| 09/19/2024 | PFIZER INC. | CIBINQO (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: ABROCITINIB CLINICAL PUBLICATION PROGRAM • Category: Inflammation & Immunology | ||||||
| 09/03/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $88.98 | General |
| Category: Inflammation & Immunology | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | VIJOICE (Drug) | Food and Beverage | In-kind items and services | $90.98 | General |
| Category: Oncology | ||||||
| 07/12/2024 | Novartis Pharmaceuticals Corporation | VIJOICE (Drug) | Food and Beverage | In-kind items and services | $53.51 | General |
| Category: Oncology | ||||||
| 07/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $46.73 | General |
| Category: Dermatology | ||||||
| 07/10/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: DERMATOLOGY | ||||||
| 07/01/2024 | PFIZER INC. | LITFULO (Drug) | Consulting Fee | Cash or cash equivalent | $2,920.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/27/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.53 | General |
| 06/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.53 | General |
| Category: Dermatology | ||||||
| 05/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/06/2024 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: RITLECITINIB CLINICAL PUBLICATION PROGRAM | ||||||
| 05/02/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Inflammation & Immunology | ||||||
| 04/23/2024 | PFIZER INC. | CIBINQO (Drug) | — | In-kind items and services | $330.00 | Research |
| Study: ABROCITINIB CLINICAL PUBLICATION PROGRAM • Category: Inflammation & Immunology | ||||||
| 04/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Immunology | ||||||
| 04/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/05/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Immunology | ||||||
| 02/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.97 | General |
| Category: Dermatology | ||||||
| 02/09/2024 | PFIZER INC. | LITFULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,275.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/07/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $105.15 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ABROCITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,270 | 2 |
| LITFULO CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $940.00 | 1 |
| RITLECITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $330.00 | 1 |
About Dr. Ilka Netravali, MD
Dr. Ilka Netravali, MD is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2016. The National Provider Identifier (NPI) number assigned to this provider is 1942658653.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ilka Netravali, MD has received a total of $28,025 in payments from pharmaceutical and medical device companies, with $10,546 received in 2024. These payments were reported across 97 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,825).
Practice Information
- Specialty Dermatology
- Other Specialties Pediatric Dermatology
- Location Palo Alto, CA
- Active Since 06/03/2016
- Last Updated 07/01/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1942658653
Products in Payments
- LITFULO (Drug) $21,106
- CIBINQO (Drug) $1,562
- DUPIXENT (Biological) $789.35
- VIJOICE (Drug) $253.09
- OPZELURA (Drug) $156.16
- OLUMIANT (Drug) $92.36
- TALTZ (Drug) $58.37
- VYJUVEK (Drug) $57.73
- RINVOQ (Biological) $57.26
- Zoryve (Drug) $46.73
- EUCRISA (Drug) $29.12
- YCANTH (Drug) $21.14
- AKLIEF (Drug) $21.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Palo Alto
John Doux, M.d, M.D
Dermatology — Payments: $124,944
Joyce Teng, Md, MD
Dermatology — Payments: $115,109
Shireen Guide, Md, MD
Dermatology — Payments: $79,371
Dr. Daniel Navi, M.d, M.D
Dermatology — Payments: $19,065
Dr. Thomas Hoffman, M.d, M.D
Dermatology — Payments: $17,860
Dr. Miguel Canales, M.d, M.D
Dermatology — Payments: $8,023